Our findings in Figure 4 and Figure 5 demonstrate decreased lactate and alanine concentration with MEK inhibition, as observed by the in vitro and in vivo 1H MRS of preclinical melanoma models. This evidence concerns the gene MAP2K7 and melanoma.